Mancera Gracia JC, Pearce DS, Masic A, Balasch M. Influenza A virus in swine: epidemiology, challenges and vaccination methods. Entrance Vet Sci. 2020;7:647.
Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, et al. Pure T cell-mediated safety towards seasonal and pandemic influenza. Outcomes of the flu watch cohort examine. Am J Respir Crit Care Med. 2015;191:1422–31.
Sridhar S, Begom S, Bermingham A, Hoschler Ok, Adamson W, Carman W, et al. Mobile immune correlates of safety towards symptomatic pandemic influenza. Nat Med. 2013;19:1305–12.
Epstein SL, Worth GE. Cross-protective immunity to influenza A viruses. Professional Rev Vaccines. 2010;9:1325–41.
Morgan SB, Hemmink JD, Porter E, Harley R, Shelton H, Aramouni M, et al. Aerosol supply of a candidate common influenza vaccine reduces viral load in pigs challenged with pandemic H1N1 virus. J Immunol. 2016;196:5014–23.
Hiremath J, Kang KI, Xia M, Elaish M, Binjawadagi B, Ouyang Ok, et al. Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs. PLoS ONE. 2016;11: e0151922.
Talker SC, Stadler M, Koinig HC, Mair KH, Rodriguez-Gomez IM, Graage R, et al. Influenza A virus an infection in pigs attracts multifunctional and cross-reactive T cells to the lung. J Virol. 2016;90:9364–82.
Patil V, Hernandez-Franco JF, HogenEsch H, Renukaradhya GJ. Alpha-d-glucan-based vaccine adjuvants: present standing and future views. Entrance Immunol. 2022;13: 858321.
Lu F, Mencia A, Bi L, Taylor A, Yao Y, HogenEsch H. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are efficient vaccine adjuvants. J Management Launch. 2015;204:51–9.
Samms KA, Alkie TN, Jenik Ok, de Jong J, Klinger KM, DeWitte-Orr SJ. Oral supply of a dsRNA-Phytoglycogen nanoparticle advanced enhances each native and systemic innate immune responses in rainbow trout. Fish Shellfish Immunol. 2022;121:215–22.
Alkie TN, de Jong J, Jenik Ok, Klinger KM, DeWitte-Orr SJ. Enhancing innate antiviral immune responses in rainbow trout by double stranded RNA delivered with cationic phytoglycogen nanoparticles. Sci Rep. 2019;9:13619.
Patil V, Renu S, Feliciano-Ruiz N, Han Y, Ramesh A, Schrock J, et al. Intranasal supply of inactivated influenza virus and poly(I:C) adsorbed corn-based nanoparticle vaccine elicited strong antigen-specific cell-mediated immune responses in maternal antibody optimistic nursery pigs. Entrance Immunol. 2020;11: 596964.
Renu S, Feliciano-Ruiz N, Patil V, Schrock J, Han Y, Ramesh A, et al. Immunity and protecting efficacy of mannose conjugated chitosan-based influenza nanovaccine in maternal antibody optimistic pigs. Entrance Immunol. 2021;12: 584299.
Chan Y, Ng SW, Singh SK, Gulati M, Gupta G, Chaudhary SK, et al. Revolutionizing polymer-based nanoparticle-linked vaccines for concentrating on respiratory viruses: a perspective. Life Sci. 2021;280: 119744.
Dhakal S, Renukaradhya GJ. Nanoparticle-based vaccine growth and analysis towards viral infections in pigs. Vet Res. 2019;50:90.
Dhakal S, Lu F, Ghimire S, Renu S, Lakshmanappa YS, Hogshead BT, et al. Corn-derived alpha-d-glucan nanoparticles as adjuvant for intramuscular and intranasal immunization in pigs. Nanomedicine. 2019;16:226–35.
Renu S, Feliciano-Ruiz N, Lu F, Ghimire S, Han T, Schrock J, et al. A nanoparticle-poly(I:C) mixture adjuvant enhances the breadth of the immune response to inactivated influenza virus vaccine in pigs. Vaccines. 2020. https://doi.org/10.3390/vaccines8020229.
Lu F, Mosley YC, Rodriguez Rosales RJ, Carmichael BE, Elesela S, Yao Y, et al. Alpha-d-glucan nanoparticulate adjuvant induces a transient inflammatory response on the injection web site and targets antigen to migratory dendritic cells. NPJ Vaccines. 2017;2:4.
Hopfner KP, Hornung V. Molecular mechanisms and mobile capabilities of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020;21:501–21.
Hernandez-Franco JF, Mosley YC, Franco J, Ragland D, Yao Y, HogenEsch H. Efficient and secure stimulation of humoral and cell-mediated immunity by intradermal immunization with a cyclic dinucleotide/nanoparticle mixture adjuvant. J Immunol. 2021;206:700–11.
Chen JR, Liu YM, Tseng YC, Ma C. Higher influenza vaccines: an trade perspective. J Biomed Sci. 2020;27:33.
Tseng YC, Wu CY, Liu ML, Chen TH, Chiang WL, Yu YH, et al. Egg-based influenza break up virus vaccine with monoglycosylation induces cross-strain safety towards influenza virus infections. Proc Natl Acad Sci USA. 2019;116:4200–5.
Vazirinejad R, Ahmadi Z, Kazemi Arababadi M, Hassanshahi G, Kennedy D. The organic capabilities, construction and sources of CXCL10 and its excellent half within the pathophysiology of a number of sclerosis. NeuroImmunoModulation. 2014;21:322–30.
Reutner Ok, Leitner J, Mullebner A, Ladinig A, Essler SE, Duvigneau JC, et al. CD27 expression discriminates porcine T helper cells with functionally distinct properties. Vet Res. 2013;44:18.
Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, et al. The way forward for immunisation coverage, implementation, and financing. Lancet. 2011;378:439–48.
Facilities for Illness C, Prevention. Ten nice public well being achievements—worldwide, 2001–2010. MMWR Morb Mortal Wkly Rep. 2011;60:814–8.
Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351:2295–301.
Luster AD, Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med. 1993;178:1057–65.
Gomez-Chiarri M, Hamilton TA, Egido J, Emancipator SN. Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in tradition. Am J Pathol. 1993;142:433–9.
Embgenbroich M, Burgdorf S. Present ideas of antigen cross-presentation. Entrance Immunol. 2018;9:1643.
Khatri M, Dwivedi V, Krakowka S, Manickam C, Ali A, Wang L, et al. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a possible animal mannequin for human H1N1 influenza virus. J Virol. 2010;84:11210–8.
Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV. The position of interleukin 6 throughout viral infections. Entrance Microbiol. 2019;10:1057.
Velazquez-Salinas L, Pauszek SJ, Stenfeldt C, O’Hearn ES, Pacheco JM, Borca MV, et al. Elevated virulence of an epidemic pressure of vesicular stomatitis virus is related to interference of the innate response in pigs. Entrance Microbiol. 2018;9:1891.
O’Gorman WE, Huang H, Wei YL, Davis KL, Leipold MD, Bendall SC, et al. The break up virus influenza vaccine quickly prompts immune cells via Fcgamma receptors. Vaccine. 2014;32:5989–97.
Woodward JJ, Iavarone AT, Portnoy DA. c-di-AMP secreted by intracellular Listeria monocytogenes prompts a number sort I interferon response. Science. 2010;328:1703–5.
Jin L, Hill KK, Filak H, Mogan J, Knowles H, Zhang B, et al. MPYS is required for IFN response issue 3 activation and sort I IFN manufacturing within the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J Immunol. 2011;187:2595–601.
Howard LM, Hoek KL, Goll JB, Samir P, Galassie A, Allos TM, et al. Cell-based methods biology evaluation of human AS03-adjuvanted H5N1 avian influenza vaccine responses: a section I randomized managed trial. PLoS ONE. 2017;12: e0167488.
Allen JD, Ray S, Ross TM. Break up inactivated COBRA vaccine elicits protecting antibodies towards H1N1 and H3N2 influenza viruses. PLoS ONE. 2018;13: e0204284.
Moliva JI, Hossfeld AP, Sidiki S, Canan CH, Dwivedi V, Beamer G, et al. Selective delipidation of Mycobacterium bovis BCG permits direct pulmonary vaccination and enhances safety towards Mycobacterium tuberculosis. Mucosal Immunol. 2019;12:805–15.
Wright AK, Bangert M, Gritzfeld JF, Ferreira DM, Jambo KC, Wright AD, et al. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog. 2013;9:e1003274.
Matthijs AMF, Auray G, Boyen F, Schoos A, Michiels A, Garcia-Nicolas O, et al. Efficacy of three modern bacterin vaccines towards experimental an infection with Mycoplasma hyopneumoniae. Vet Res. 2019;50:91.
Luo Y, Van Nguyen U, de la Fe Rodriguez PY, Devriendt B, Cox E. F4+ ETEC an infection and oral immunization with F4 fimbriae elicits an IL-17-dominated immune response. Vet Res. 2015;46:121.
Talker SC, Koinig HC, Stadler M, Graage R, Klingler E, Ladinig A, et al. Magnitude and kinetics of multifunctional CD4+ and CD8beta+ T cells in pigs contaminated with swine influenza A virus. Vet Res. 2015;46:52.
Kick AR, Amaral AF, Cortes LM, Fogle JE, Crisci E, Almond GW, et al. The T-cell response to sort 2 porcine reproductive and respiratory syndrome virus (PRRSV). Viruses. 2019. https://doi.org/10.3390/v11090796.
De Pelsmaeker S, Devriendt B, De Regge N, Favoreel HW. Porcine NK cells stimulate proliferation of pseudorabies virus-experienced CD8(+) and CD4(+)CD8(+) T cells. Entrance Immunol. 2018;9:3188.
Franzoni G, Kurkure NV, Edgar DS, Everett HE, Gerner W, Bodman-Smith KB, et al. Evaluation of the phenotype and performance of porcine CD8 T cell responses following vaccination with reside attenuated classical swine fever virus (CSFV) and virulent CSFV problem. Clin Vaccine Immunol. 2013;20:1604–16.
Rosenbaum P, Tchitchek N, Joly C, Rodriguez Pozo A, Stimmer L, Langlois S, et al. Vaccine inoculation route modulates early immunity and consequently antigen-specific immune response. Entrance Immunol. 2021;12: 645210.
Del Giudice G, Rappuoli R, Didierlaurent AM. Correlates of adjuvanticity: a overview on adjuvants in licensed vaccines. Semin Immunol. 2018;39:14–21.
de Jong SE, Olin A, Pulendran B. The affect of the microbiome on immunity to vaccination in people. Cell Host Microbe. 2020;28:169–79.
Ali A, Khatri M, Wang L, Saif YM, Lee CW. Identification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs. United States Vet Microbiol. 2012;158:60–8.
Yassine HM, Khatri M, Zhang YJ, Lee CW, Byrum BA, O’Quin J, et al. Characterization of triple reassortant H1N1 influenza A viruses from swine in Ohio. Vet Microbiol. 2009;139:132–9.
Yassine HM, Al-Natour MQ, Lee CW, Saif YM. Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses. Virol J. 2007;4:129.
Dhakal S, Hiremath J, Bondra Ok, Lakshmanappa YS, Shyu DL, Ouyang Ok, et al. Biodegradable nanoparticle supply of inactivated swine influenza virus vaccine offers heterologous cell-mediated immune response in pigs. J Management Launch. 2017;247:194–205.
Dhakal S, Cheng X, Salcido J, Renu S, Bondra Ok, Lakshmanappa YS, et al. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protecting immune response in pigs. Int J Nanomedicine. 2018;13:6699–715.